|
|
||||||||
The Journal of Immunology, Vol 144, Issue 6 2082-2088, Copyright © 1990 by American Association of Immunologists
ARTICLES |
IJ Molina and BT Huber
Department of Pathology, Tufts University School of Medicine, Boston, MA 02111.
We have compared the functional properties of I-Ad expressed on different cell types. Specifically, we have transfected I-A alpha d and I-A beta d cDNA into a panel of T cell thymomas of various phenotypes. Excellent class II surface expression was achieved in all T cell tumors, equivalent in level to that found on the B cell lymphoma A20. Interestingly, however, two allo-I-Ad-specific Thy differed in their recognition of the transfected tumor cells: whereas the 42H11 T cell hybridoma (THy) was stimulated very efficiently by all transfectants, the RK38.2.2 Thy did not react to any of them. Both THy responded equally well to I-Ad on A20 B lymphoma cells. Purified macrophages isolated from various sources were also differentially recognized by the two THy, although there was only a quantitative difference in stimulation. Taken together, these results are best interpreted to show that the TCR of the RK38.2.2 THy is specific for I-Ad in the context of a B cell-specific determinant, possibly a self-peptide that is naturally associated with Ia. A cross-reactive molecule could be expressed by macrophages and COS-1 cells, but not by T cells.
This article has been cited by other articles:
![]() |
H. S. de Koster, C. J. Vermeulen, H. S. Hiemstra, R. Amons, J. W. Drijfhout, and F. Koning Definition of agonists and design of antagonists for alloreactive T cell clones using synthetic peptide libraries Int. Immunol., April 1, 1999; 11(4): 585 - 591. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |